共 25 条
Salvianolic acid B suppresses IFN-γ-induced JAK/STAT1 activation in endothelial cells
被引:40
作者:
Chen, Shih Chung
[2
,3
]
Lin, Yun Lian
[1
]
Huang, Bin
[4
]
Wang, Danny Ling
[5
,6
]
Cheng, Jing Jy
[1
]
机构:
[1] Natl Res Inst Chinese Med, Taipei 112, Taiwan
[2] New Taipei City Hosp, Dept Cardiol, New Taipei City, Taiwan
[3] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan
[4] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan
[5] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan
[6] Tzu Chi Univ, Inst Med Sci, Coll Med, Hualien, Hualien County, Taiwan
关键词:
salvianolic acid;
endothelial cells;
JAK;
STAT1;
IP-10;
IFN-gamma;
HUMAN ATHEROSCLEROTIC PLAQUES;
JAK-STAT;
EXPRESSION;
RECEPTOR;
MICE;
INTERLEUKIN-6;
INFLAMMATION;
LYMPHOCYTES;
CHEMOKINES;
MIGRATION;
D O I:
10.1016/j.thromres.2011.08.032
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Introduction: Dysfunction of the endotheliumcontributes to pathological conditions of the arterialwall including atherosclerosis as a result of immunological and/or inflammatory responses. Salvianolic acid B (Sal B), a pure and active compound extracted from the Chinese herb Salvia miltiorrhizae (SM) was characterized for its anti-inflammatory and anti-oxidant properties on vascular system. Methods and Results: Sal B pretreatment significantly inhibited the IFN-gamma-induced phosphorylations of JAK2 (Tyr 1007/1008) and STAT1 (Tyr701 and Ser727). Consistently, IFN-gamma-induced STAT1 downstream targets CXC chemokines' IP-10, Mig, and I-TAC were suppressed by Sal B pretreatment. Sal B inhibited promoter activities of IP-10 and the secretion of IP-10 protein. The monocyte adhesion to IFN-gamma-treated ECs was observed to be reduced after Sal B pretreatment. ECs treated with Sal B alone also increased the expression of PIAS1 and SOCS1 which may also contribute to its inhibitory effect on JAK-STAT1 signaling pathways. Conclusions: The anti-inflammatory properties of Sal B on IFN-gamma-induced JAK-STAT1 activation were demonstrated in the present study which provides a molecular basis for possible therapeutic usage on vascular disorders. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:560 / 564
页数:5
相关论文